Wednesday 26 October 2016 - Room 109/110, Level 1, Melbourne Convention Centre
8.30am - 4.30pm Registration desk open
9.00 - 9.05am

Welcome and Official Opening

Glenn Cross, Chief Executive Officer, AusBiotech

9.05 - 9.10am

Welcome Address
The Hon Philip Dalidakis, Minister for Small Business, Innovation & Trade

9.10 - 9.30am

Keynote: Biotech investing in a global market: Leveraging US / Australian Opportunities

Warren Dunnavant, Director - Investment Banking, ROTH Capital Partners, LLC

9.30 - 10.05am

Panel: International Investment Update

Moderator: Hershel Berry, Managing Partner, Blueprint Life Science Group



Dr Stuart Collinson, Director, Forward Ventures

Dr Ron Laufer, Senior Managing Director, MedImmune Ventures
Gordon Waldron, President, Sequoia Business Solutions SAS, France

10.05 - 10.30am

Company spotlight presentations

John Martin, CEO, Regeneus

Dr James Garner, CEO, Novogen

Dr Michelle Fraser, Managing Director & CEO, Reproductive Health Science

10.30 - 11.00am Morning Tea and networking with exhibitors
11.00 - 11.45am

Panel: Big Pharma

Moderator: Lorraine Chiroiu, Deputy CEO, AusBiotech


Dr Jeanne Bolger, Vice President Venture Investments, Johnson & Johnson Innovation 

Dr Chris Carol Bremer, Senior VP/Head, Commercial Strategy & Market Insights Europe & Australia, Grunenthal Europe
Dr Yuan-Hua Ding, External R&D Innovation - Asia Pacific, Pfizer
Dr Reginald Seeto, Head of Partnering and Strategy, MedImmune

Dr Will Shen, Director, Mergers & Acquisitions, Bristol-Myers Squibb

11.45am - 12.25pm

Company spotlight presentations

Dr Paul MacLeman, Managing Director & CEO, IDT Australia

Peter Culpepper, Interim CEO, Provectus Biopharmaceuticals

Dr Ross Murdoch, CEO & Managing Director, Phosphagenics

Dr Karen Duggan, CEO, Vectus Biosystems

12.25 - 1.30pm Lunch and networking with exhibitors
1.30 - 2.00pm

Company spotlight presentations

Dr Jeremy Chrisp, CEO, EpiAxis

Sam Cobb, CEO, AdAlta Ltd

Dr David Fisher, Executive Director, GI Therapies

2.00 - 3.00pm

Panel: Alternative Funding

Moderator: Dr Amanda Gillon, Investment Manager, Bioscience Managers



Ross Curtin, CEO, WealthSpring International Group

Ram May-Ron, Managing Partner, FreeMind Group

 3.00 - 3.30pm

Afternoon tea and networking with exhibitors

 3.30 - 4.00pm

Company Spotlight Presentations

Peter Molloy, CEO, Race Oncology
Paul Anderson, Managing Director, Orthocell

Garth Sutherland, Group CEO, Adherium

 4.00 - 4.40pm

Panel: Australian Stockbrokers

Moderator: Dr Amanda Gillon, Investment Manager, Bioscience Managers



Joanna Hill, Financial Advisor, Baillieu Holst

Sam Street, Director - Corporate Finance, Morgans Financial

Anton Whitehead, Director - Equity Capital Markets, Bell Potter

4.40 - 4.45pm

Close of conference day 1

4.45 - 6.00pm

International BioFest Networking Reception

Held in conjunction with AusBiotech 2016 and the International Biotechnology Symposium

Melbourne Convention Centre, Level 2, Foyer


Thursday 27 October 2016 - Room 109/110, Level 1, Melbourne Convention Centre
8.30am - 3.30pm Registration desk open
9:00 - 9:05am

Conference Chairman opening remarks and recap of day one

Mark Pachacz, Analyst, Bioshares

9.05 - 9.25am

Keynote: Investing in biotech - A global perspective
Dr Bianca Ogden, Portfolio Manager, Platinum Asset Management Ltd

9.25 - 10.00am

Panel: Life science investment in Asia

Moderator: Mark Pachacz, Analyst, Bioshares

Donald Xu, Managing Director, Lynx Financial

CT Johnson, General Manager, Basis Point

Rob Scott, Director, China BlueSky Partners

10.00 - 10.30am

Company spotlight presentations
Dr Michelle Miller, CEO & Managing Director, Biotron Ltd

Elaine Darby, Managing Director, AusCann Group Holdings

Dr Deborah Rathjen, CEO & Managing Director, Bionomics

10.30 - 10.40am

Keynote: ASX update - New listings and admissions requirements

Rory Cunningham, Manager - Listings Business Development, ASX Ltd

10.40 - 11.10am

Morning tea and networking with exhibitors

11.10 - 11.30am

Keynote: Texas Medical Centre and Bio Bridge to Australia

Bill McKeon, Executive Vice President, Chief Strategy and Operating Officer, Texas Medical Centre

11.30 - 12.00pm

Panel: Investing in digital health

Moderator: Bronwyn Le Grice, Principal, Fidere Group


Andrew Ronchi, CEO, DorsaVi

Sam Holt, CEO, GP2U

12.00 - 12.40pm

Company Spotlight Presentations

Arie Nudel, Managing Director, Omniblend Innovation

Ross Barrow, CEO & Director, Paranta Biosciences
Dr Richard Lipscombe, Managing Director, Proteomics International Labs

Dr Andrew Bray, CEO, Elk OrthoBiologics

12.40 - 2.00pm

Lunch and networking with exhibitors

Supported by Bristol-Myers Squibb

 2.00 - 2.20pm

Keynote: Icing a globally competitive biotech industry: The Canadian Experience

Andrew Casey, President & CEO, BIOTECanada

2.20 - 3.10pm

Company spotlight presentations

Brent Barnes, CEO & Managing Director, LBT Innovations

Julie Phillips, Managing Director, Opal Biosciences
Ben Foskett, Chair, Nanjing Biopoint

2.50 - 3.30pm

Panel: New model for medical device investing

Moderator: Paul Carboon, Business Development Manager, Hydrix

Richard Hannebery, Lodge Partners

Peter Rowland, CEO, Micro-X Pty Ltd

3:30 - 3:45pm

Company spotlight presentations
Peter Saunders, CEO & Co-Founder, Health Delivered

Dr James Freeman, CEO, SkinView

Philip Crealy, Director - Translational Research, Petri Exchange

3:45 - 4:00pm Chairmans closing remarks and end of conference